Methods: Simulations were conducted based on proposed or ongoing Vaccine Safety Datalink studies. We simulated 4 studies of 2 exposure groups (children with no vaccines or on alternative schedules) and 2 baseline outcome levels (100 and 1000/100 000 person-years), with 3 relative risk (RR) levels (RR = 0.50, 1.00, and 2.00), across 1000 replications using probabilistic modeling. We quantified bias from non-differential and differential outcome misclassification, based on levels previously measured in database research (sensitivity > 95%; specificity > 99%).
1-3 These systems capture data on millions of individuals and billions of medical encounters from electronic health records (EHR) and medical billing claims. 2, 4 Clinical outcomes are identified with electronic data algorithms, which are typically individual or combinations of diagnosis codes. 5, 6 In studies of acute vaccine adverse events, presumptive outcomes are identified in electronic data within short risk and control periods around vaccination. Misclassification of these presumptive outcomes has been a key challenge in this research. 2 Common reasons for misclassification include clinician miscoding and rule-out diagnoses. 5 To avoid misclassification bias, researchers often chart review all presumed outcomes and then re-analyze data with only confirmed outcomes. 2 The percent of presumed outcomes confirmed is typically reported as a positive predictive value (PPV) or confirmation rate. 7 Vaccine safety studies have demonstrated considerable variability in outcome PPVs, ranging from 5% to 97%. 8, 9 While there has been ample research on acute outcomes following vaccination, a 2013 Institute of Medicine report called for studies of chronic outcomes, such as autoimmune and allergic diseases, following cumulative exposure to early childhood immunizations. 10 The VSD has embarked on such studies of immunization schedule studies, 11 but this research poses new challenges for addressing outcome misclassification bias. Unlike studies of acute outcomes, observation time will span years. It may not be feasible to adjudicate the hundreds or thousands of presumptive outcomes identified in electronic data. 11 Furthermore, outcome sensitivity is a concern, because for some non-acute conditions, parents may have varying propensity to seek care for their children, or may consult external providers not captured in EHRs. 12 In this study, we used simulations to evaluate a method for assessing and another method for correcting bias of an immunization schedule-outcome association due to outcome misclassification in EHR data. The first method involves using overall outcome PPVs to assess misclassification bias. PPVs are the most commonly reported measure of electronic algorithm validity in EHR-based research. 13 For immunization schedule safety studies, researchers could validate a sample of presumptive outcomes and estimate an outcome PPV. While it has been suggested that PPV levels >70% are sufficient for electronic-only data analysis, 14 the relation between overall outcome PPVs and bias of an exposure-outcome association has not been investigated for EHR-based vaccine schedule safety research. We also evaluated quantitative bias analyses (QBA), which are methods for correcting systematic error in epidemiological research. 15, 16 Traditional QBA formulas for outcome misclassification apply sensitivity and specificity estimates to a study's observed relative risk. Previous studies have reported the sensitivity and specificity for several chronic outcomes of interest in immunization schedule safety studies [17] [18] [19] [20] [21] ; these measures could be used as bias parameters in QBA.
For our primary objective, we evaluated whether outcome PPVs are effective indicators of bias of an immunization schedule-outcome association. To achieve this objective, we constructed simulations modeled on VSD studies that have been proposed or are ongoing, applied outcome misclassification levels previously measured in EHR data, and calculated the resulting misclassification bias and outcome PPVs. As a secondary objective, we tested the effectiveness of QBA for outcome misclassification within the same simulations. 15, 16 We examined both outcome misclassification that is independent of exposure (non-differential misclassification), and misclassification that systematically varies by exposure (differential misclassification).
2 | METHODS
| Study setting
We sought to have our simulations mimic actual VSD cohort studies of immunization schedule safety. To achieve this goal, we first identified a cohort of children born 2002 to 2012 from 2 managed care organizations (MCOs) participating in the VSD, Kaiser Permanente Colorado, and Kaiser Permanente Northern California. We further limited the cohort to children continuously enrolled in their MCO from birth to their second birthday, which is the period when early childhood immunizations are administered. 22 We used actual birthdates and MCO enrollment time (ie, person-time) in our analyses; all other data in this study were simulated.
Both MCOs' Institutional Review Boards approved this study;
informed consent was not required.
| Simulations
Within this VSD cohort, we constructed simulations of immunization schedule safety studies, where risks of chronic outcomes are compared between groups of children with different immunization patterns in early childhood (ages 0-2 years). Table 1 provides an overview of our simulations, relative risk (RR) levels, and outcome misclassification scenarios. We simulated outcomes with the formula [23] [24] [25] :
where p(outcome = 1) is an individual's probability of having the outcome, pt is person-time contributed (in days) from each child's second birthday to the first of MCO disenrollment or eighth birthday, β 0 is the log of baseline outcome rate (per day), β 1 is the log of the simulated RR, and X 1 indicates under-vaccination exposure. The second term in Equation 1 represents the daily probability of experiencing an outcome. The probability of experiencing an outcome during the entire follow-up period is the product of the daily probability and pt. Simulated RR refers to the true RR representing the association between under-vaccination exposure and outcome, absent of any bias.
KEY POINTS
• Bias from misclassification of outcomes in electronic health record data is a methodological challenge in immunization schedule safety studies.
• Using simulations, we evaluated outcome positive predictive values (PPVs) as indicators of bias of an immunization schedule-outcome association, and quantitative bias analyses for addressing this bias.
• While outcome PPVs reflected the magnitude of median bias with non-differential outcome misclassification, these metrics were not effective indicators of median bias with differential misclassification.
• With differential outcome misclassification, Type 1 error rates of 100% were observed with outcome PPVs of 90%.
• Quantitative bias analysis was effective in correcting outcome misclassification bias and should be considered in immunization schedule research. Practices' (ACIP) recommended schedule. 10, 22 Therefore, for X 1 , we focused on children with no vaccines before their second birthday and children whose parents choose distinct alternative schedules popularized in books or on the internet. [26] [27] [28] Based on previous research, we simulated the prevalence of these 2 groups at 0.7% and 2.4%, respectively. The unexposed group was simulated to be children fully vaccinated per the ACIP schedule with a prevalence of 60.6%. 29 The remaining 36.3% of children are assumed to be missing some vaccine doses or are under-vaccinated at some point but get caught up before their second birthday; these less distinct patterns of under-vaccination
were not considered in this study.
We simulated 2 levels of baseline outcome incidence: 100 and 1000 outcomes per 100 000 person-years. We chose these rates to represent both rare (eg, Type 1 diabetes, epilepsy) and more common (eg, allergic conditions, asthma) conditions from a priority list of outcomes for VSD immunization schedule research. 11 Within each of 4 simulations (1 for each of 2 exposure groups and 2 baseline outcome incidence levels), we separately simulated 3 levels of RR: 2.00, 1.00, and 0.50. For each simulation and RR level, we created 1000 replicated datasets with a different random seed. Within each replication, exposure probabilities were applied to each child, and Bernoulli trials determined which children were assigned exposure to an under-vaccination pattern. Formula 1 was used to assign probability of outcome, and
Bernoulli trials determined the outcome status for each child.
| Misclassification
We reviewed published studies to identify ranges of likely outcome misclassification levels in VSD immunization schedule research. We identified validation studies of EHR-based algorithms for 2 outcomes of interest: asthma and Type 1 diabetes. 11 The best performing algorithms had sensitivity > 95% and specificity > 99%. 17, 18 For each simulation and RR, we made 4 copies of the 1000 replicated datasets and tested 2 scenarios of non-differential and 2 scenarios of differential outcome misclassification based on these levels ( Table 1, scenarios A-D). For 1 differential outcome misclassification scenario, we measured bias with lower outcome sensitivity among under-vaccinated children. Some parents who refuse vaccines express distrust in traditional medicine and may seek care outside the MCO, 12 leading to decreased outcome sensitivity. We then measured bias from lower outcome specificity among under-vaccinated children. Clinicians may be more likely to suspect infectious conditions in ill children who are under-vaccinated, which could lead to more "rule-out" diagnoses and higher false positive rates.
When testing the 2 non-differential outcome misclassification scenarios, we applied sensitivity and specificity levels from Table 1 to the simulated datasets without regard to exposure. For the 2 presentations of differential misclassification, sensitivity and specificity were applied Abbreviations: RR, relative risk; SN, overall sensitivity; SN 1 , sensitivity among exposed; SN 0 , sensitivity among unexposed; SP, overall specificity; SP 1 , specificity among exposed; SP 0 , specificity among unexposed.
a 1000 replicated datasets were generated for each simulation and relative risk level using probabilistic modeling. Four copies of these 1000 datasets were generated to test the 2 non-differential and 2 differential outcome misclassification scenarios.
b We simulated the prevalence of completely unvaccinated children to be 0.7% and children on distinct alternative immunization schedules to be 2.4%. We simulated the unexposed group to be children fully vaccinated per the US Advisory Committee on Immunization Practices' recommended schedule, with an estimated prevalence of 60.6%. The remaining 36.3% of children are assumed to be missing some vaccine doses or are under-vaccinated at some point but get caught up on vaccines before their second birthday, and these under-vaccination patterns were not considered in this study.
c The lower sensitivity (scenario C) and specificity (scenario D) levels occur in a rare exposure group. Because overall outcome sensitivity and specificity levels will be a weighted average of these levels from across the exposed and unexposed groups, the overall observed sensitivity and specificity will be closer to the value in the more common unexposed group.
separately by exposure. Bernoulli trials determined which children "flipped" to an outcome false positive or false negative status, representing EHR data misclassification.
| Analysis
We calculated the observed RR, using Poisson regression with a log of We tested the effectiveness of QBA using formulas for both QBA assuming non-differential outcome misclassification and assuming differential outcome misclassification (Appendix 1). 15, 16 To conduct the QBA, we determined the number of observed individuals that were exposed with outcome, exposed without outcome, unexposed with outcome, and unexposed without outcome in each simulated replication. We then applied QBA formulas with sensitivity and specificity measured from each replication and calculated the RR that would have been observed had misclassification not been present. We reported the median QBA-corrected RRs across replications.
All simulations and analyses were conducted using SAS 9.4®.
| RESULTS
Across replications, there were an average of n = 1722 children simulated to be completely unvaccinated (simulations #1 and #2), n = 6117 children simulated to be on a distinct alternative schedule (simulations #3 and #4), and n = 155 722 children simulated to be adhering to the ACIP schedule (unexposed group in all simulations). We observed a range of bias across the simulations, levels of simulated (ie, true) RR, and misclassification scenarios tested. Across simulations, overall median outcome PPVs ranged from 34% to 98%. With non-differential misclassification, median bias was across replications was toward the null and overall outcome PPVs were associated with the magnitude of median bias (Tables 2a-2b , scenarios A and B). For example, when true RR = 2.00, the median observed RR was 1.33 when the median PPV = 34%, and the median observed RR was 1.83 when the median PPV = 85%. When the median PPV was 98%, there was virtually no bias of the median RR.
When outcome misclassification was differential to exposure, the direction of median bias varied, and overall PPVs were not indicators of the direction or magnitude of median bias (Tables 2a-2b, scenarios C and D). For example, when true RR = 2.00 and the baseline outcome rate was 1000/100 000 person-years, the median observed RR was 1.65 when outcome sensitivity was lower among under-vaccinated children and 2.23 when specificity was lower among under-vaccinated children. In both scenarios, median overall outcome PPVs were 91% or 92%. In some simulations, differential misclassification caused extreme median bias. For example, in simulation #1, with lower specificity among under-vaccinated children (scenario D), the observed median RR was 2.72 when true RR = 0.50, and median PPV = 50%.
| Power and Type 1 error
In some simulations, outcome misclassification led to reductions in power (Table 3 ). For example, for true RR = 2.00 in simulation #1, power was reduced from 78% without any misclassification to 70%
with non-differential specificity = 99.9% and PPV = 84% (scenario B), and further down to 40% power with non-differential specificity = 99.0% and PPV = 34% (scenario A). Change in power varied by true RR within the same differential misclassification scenario. For example, when specificity was lower among under-vaccinated children (scenario D), the higher outcome false positive rate in this exposed group led to consistent overestimation of the true effect. Therefore, when simulated RR = 0.50, power was reduced from 100% without misclassification to 17% with misclassification, but power remained at 100% when RR = 2.00 (simulation #2).
Before misclassification was applied, Type 1 error was near 5% in all simulations where simulated RR = 1.00. Non-differential outcome misclassification did not affect these rates (results not shown). However, differential misclassification led to Type 1 error up to 100%, and overall PPV levels were not associated with these rates (Table 4) .
For example, in simulations #3 and #4 with differential outcome sensitivity (scenario C), median PPV = 51% and Type 1 error = 7.1% when the baseline outcome rate was 100/100 000 person-years. In contrast, median PPV = 92% and Type 1 error = 67.8% when the baseline outcome rate was 1000/100 000 person-years. While the higher false negative rate among under-vaccinated children led to bias toward observing a protective effect, the specificity of 99.5% more rapidly caused the observed effect back toward the null with the rarer outcome, leading to lower Type 1 error.
| Quantitative bias analysis
In most simulations of non-differential misclassification, QBA assuming non-differential misclassification corrected bias (Tables 2a-2b,   Table 4 ). When true RR = 2.00, QBA assuming non-differential misclassification resulted in perfect or near-perfect bias correction.
QBA assuming non-differential misclassification was also effective when true RR = 0.50, except in Simulation #1. In that simulation with completely unvaccinated children and the rarer outcome, median bias-corrected RR was 0.67 with QBA assuming non-differential misclassification. This median bias-corrected RR was closer to the true value of RR = 0.50 than the median RR observed with misclassification of 0.84.
QBA using outcome sensitivity and specificity measurements by exposure group led to nearly perfect correction of bias in all simulations. Unsurprisingly, when misclassification was simulated to be differential by exposure, QBA assuming non-differential misclassification was ineffective, and sometimes resulted in estimates that were more biased than the estimates observed under misclassification.
| DISCUSSION
While numerous studies have reported on misclassification in pharmacoepidemiological databases, 6, 13, 14, 30, 31 there has been limited work in quantifying the bias that arises from such misclassification and on methods for correcting this bias. To our knowledge, there has been no prior work on evaluating and correcting misclassification bias in vaccine schedule research studies. Using simulations, we quantified a range of bias across plausible scenarios of non-differential and differential outcome misclassification. Our results suggest that rather than relying on overall PPVs as indicators of bias, quantitative methods should be used to account for misclassification bias.
Our results highlight several reasons why overall outcome PPVs may not be effective indicators of bias of an exposure-outcome association. First, while median PPVs were associated with the magnitude of median bias with non-differential misclassification, they were not associated with the magnitude or direction of median bias with differential misclassification. In immunization schedule research, differential outcome misclassification could occur due to parent or provider behavior. 11, 12, 32 Even if non-differential outcome misclassification is presumed, exactly equal misclassification levels across exposure groups are not guaranteed. 33 Differential misclassification can lead to bias toward or away from the null, and the direction of bias is often unpredictable. 34, 35 Second, because predictive values are a function of 3 factors (specificity, sensitivity, and prevalence; see Appendix 2), 5, 36 PPVs can fluctuate based on any of these factors. For example, we observed extreme differences in PPV, from 34% to 84%, from a 0.9% difference in specificity when outcome prevalence was low.
Because overall outcome PPVs do not reflect the distribution of false positives by exposure (an underlying cause of bias of an exposure-outcome association), these metrics have limited utility for assessing bias in individual studies. Instead, quantitative methods to adjust for systematic error should be considered. The tendency to underestimate misclassification error, along with a lack of practical examples, has been identified as barriers to implementing QBA. 16 We addressed these barriers by measuring bias via simulation and by Abbreviations: PPV, positive predictive value; QBA, quantitative bias analysis; RR, relative risk; SN, overall sensitivity; SN 1 , sensitivity among exposed; SN 0 , sensitivity among unexposed; SP, overall specificity; SP 1 , specificity among exposed; SP 0 , specificity among unexposed. Abbreviations: RR, relative risk; SN, overall sensitivity; SN 1 , sensitivity among exposed; SN 0 , sensitivity among unexposed; SP, overall specificity; SP 1 , specificity among exposed; SP 0 , specificity among unexposed. evaluating the application of QBA in immunization schedule safety research. Our results showed that QBA was typically effective in correcting outcome misclassification bias. However, similar to previous findings by Johnson and colleagues, we found that QBA is vulnerable to assumptions made and bias parameters used. 40 For example, in simulation #1, with a rare exposure and rare outcome, QBA assuming nondifferential misclassification did not effectively correct misclassification bias when true RR = 0.50, even though the underlying misclassification process was non-differential. This was due to differences in sensitivity and specificity by exposure that occurred due to chance.
For traditional QBA methods to be most effective in immunization schedule research, our results suggest that outcome sensitivity and specificity should be estimated by exposure. Because collecting such data may not be feasible, an alternative approach is to establish ranges of plausible sensitivity and specificity levels by exposure, and use probabilistic bias analysis to quantify a range of corrected RRs. 15, 39 Lessestablished quantitative bias approaches using predictive values are available. 15, 41, 42 However, these methods come with challenges, including requiring positive and negative predictive values stratified by exposure, 15 or assuming non-differential outcome sensitivity. 41 While we investigated traditional QBA methods for misclassification using sensitivity and specificity measures, evaluation of predictive value-based approaches is also warranted in EHR-based research.
Our study has several limitations. Our simulations did not incorporate all outcome misclassification levels encountered in immunization schedule safety research. Also, while our differential misclassification scenarios were based on practical concerns in immunization schedule research, it is unknown how different outcome sensitivity and specificity levels actually are across exposure groups, because these data have not been collected. As a result, our simulations may have over-estimated or under-estimated the misclassification bias that may be encountered in this line of research. Moreover, our simulations only focused on bias from misclassification of binary outcomes. Exposure misclassification due to missing vaccine records is also a concern.
Addressing measurement error of exposures, covariates, and of continuous or multi-level outcome variables, along with bias from unmeasured confounding, involves more complex bias analyses which merit further evaluation within EHR-based research. 15 Finally, we only considered bias of risk ratios and did not evaluate how outcome misclassification in EHR data would affect measures of risk difference.
Research using electronic databases are essential to US vaccine safety, and improved methods for quantifying and communicating about uncertainty in this line of research are needed. 43 While our simulations were conducted in the context of immunization schedule safety research, our findings are broadly applicable to other EHRbased pharmacoepidemiological research. Our results serve to encourage researchers to acknowledge the potential for misclassification bias in EHR-based studies, and to use quantitative techniques for identifying, measuring, and correcting this bias.
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